Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer

Although numerous genetic mutations and amplifications have been identified in pancreatic cancer, much of the molecular pathogenesis of the disease remains undefined. While proteomic and transcriptomic analyses have been utilized to probe and characterize pancreatic tumors, lipidomic analyses have n...

Full description

Bibliographic Details
Main Authors: Todd E. Fox, Mark Kester, Timothy M. Ritty, Yixing Jiang, Nicole A. DiVittore, Megan M Young, Zhiliang Jia, Keping Xie
Format: Article
Language:English
Published: MDPI AG 2013-07-01
Series:Biomolecules
Subjects:
Online Access:http://www.mdpi.com/2218-273X/3/3/435